EPO and cancer: Since, treatment of various cancer cell lines with EPO in vitro elicits secretion of angiogenic growth factors and promotes cell proliferation [42], processes regulated by eIF4E, therapeutic suppression of translation initiation factor eIF4E in EPO-treated patients might provide an attractive new approach to the treatment of human malignancies.